LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heavy metal containing doai

Use of phosphotyrosine phosphatase inhibitors or phosphotyrosine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Use of photodynamic compositions for cytotoxic effects

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Use of photodynamic therapy for prevention of secondary cataract

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Use of photodynamic therapy for prevention of secondary...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Silicon containing doai

Use of photodynamic therapy to treat prostatic tissue

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Use of phthalazine derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of Phthalidyliden esters of carnitine and alkanoyl carnitine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Use of phthaloylhydrazide derivatives as anti-hypoxic and defens

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of phthalyltaurine sulfonamide derivatives in treating epile

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Use of phytosteryl glycosides for the treatment of epoxycholeste

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of piperidine derivatives as dermo-decontracting agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Use of pirenoxine for the protection of corneal tissues in...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of pirfenidone in therapeutic regimens

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of piribedil derivatives and analogs for the treatment of hy

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Use of PKC-activating compounds as cardioprotectants and as...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of PLA.sub.2 inhibitors as treatment for alzheimer's disease

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Use of placental growth factor for treating ischemic muscle...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of plasminogen activators to stimulate local bone growth

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Use of platelet activating factor antagonists as...